Improving the Early Detection of Cardiometabolic Disease Risk

NCT ID: NCT05885672

Last Updated: 2024-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-11

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to reduce an individual's cardiometabolic disease risk by improving the ability to detect cardiometabolic disease risk in young adults through the use of novel technologies that increase access to and examine the utility of, a continuous metabolic syndrome severity score. An additional goal of this study is to understand the barriers to engagement in health-promoting behaviors and beliefs about interventions aimed at mitigating metabolic syndrome risk through a brief online lifestyle intervention.

The main question\[s\] it aims to answer are:

* Can a smartphone-based imaging system accurately predict a continuous metabolic syndrome severity score, in addition to other markers of cardiometabolic disease, in young adults?
* What is the relationship between autonomic dysfunction and metabolic syndrome severity in a cohort of young adults?
* What is the relationship between peripheral vascular dysfunction and metabolic syndrome severity in a cohort of young adults?
* What are the associations between metabolic syndrome severity and gait and functional ability in young adults using novel markerless motion capture technology?
* What are the attitudes and barriers towards lifestyle interventions targeted to reduce metabolic syndrome severity?
* What are the treatment-seeking and willingness to engage behaviors toward a webpage focused on lifestyle interventions to reduce metabolic syndrome severity?

Participants will be asked to undergo several assessments across four separate days which are design designed to determine the associations between cardiometabolic health markers and components of:

* body composition
* cardiovascular function
* functional ability
* attitudes and behaviors towards health-related interventions

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Young Adults

Adults between the ages of 18 and 39 years

Online psychoeducational lifestyle intervention

Intervention Type BEHAVIORAL

A webpage-baed intervention focused on lifestyle interventions that aim to reduce metabolic syndrome severity.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online psychoeducational lifestyle intervention

A webpage-baed intervention focused on lifestyle interventions that aim to reduce metabolic syndrome severity.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- adults between the ages of 18-39 years of age

Exclusion Criteria

* Younger than 18 or older than 39
* Pregnant
* Breastfeeding or lactating
* Missing any limbs or part of a limb
* Having a substantial amount of metal implants (metal plates or complete joint replacements)
* Having a pacemaker or any other electrical implant
* Type I diabetes
* Gestational diabetes
* Taking insulin
* Diagnosed heart failure, cardiomyopathy (dilated or hypertrophic), valvular disease
* Any history of severe traumatic brain injury or mild traumatic brain injury within the last two years
* Kidney disease
* Liver disease
* Thyroid disease
* Any diagnosed neurological or neurodegenerative diseases
* Having received ionizing radiation from a medical procedure within the last 30 days
* Being on a medically prescribed diet
* Having donated blood or plasma in the last 20 days prior to blood collection procedures
* Taking any supplements/medications that may interfere with the results of the study
* Any injury or physical impairment that would prevent performing any functional measures for this study
Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Mississippi Medical Center

OTHER

Sponsor Role collaborator

University of Southern Mississippi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Austin J Graybeal, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Southern Mississippi

Jon Stavres, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Southern Mississippi

Tanner Thorsen, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Southern Mississippi

Megan Renna, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Southern Mississippi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Southern Mississippi - School of Kinesiology and Nutrition

Hattiesburg, Mississippi, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Graybeal AJ, Compton AT, Swafford SH, Brandner CF, Thorsen T, Renna ME, Stavres J. Measurements of Abdominal Obesity are Associated with Metabolic Syndrome Severity Independent of Hypertensive Phenotype in White but not Black Young Adults. J Racial Ethn Health Disparities. 2025 Aug;12(4):2299-2311. doi: 10.1007/s40615-024-02051-8. Epub 2024 Jun 20.

Reference Type DERIVED
PMID: 38902464 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-0446

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.